What we prioritize first Before focusing on GLP-1 dosing terminology, we prioritize the clinical fundamentals that have the strongest relevance to cognitive longevity: blood pressure optimization ApoB, LDL, triglyceride, and lipoprotein(a) risk assessment insulin resistance and glucose-pattern evaluation visceral fat and body-composition measurement resistance training and aerobic fitness sleep quality and sleep apnea evaluation when appropriate hearing and vision support nutrition quality and protein adequacy alcohol moderation inflammation and immune-metabolic context hormone evaluation when clinically indicated social connection, cognitive engagement, and meaningful activity None of these interventions is glamorous by itself
Therefore, the CJC-1295/ipamorelin may be best dosed twice a day
7 Discussion Current research suggests a close relationship between glucose metabolism disorders and energy conversion disorders and PD pathogenesis
This is an especially good strategy for semaglutide users who struggle with appetite and want to maximize nutrition in fewer eating opportunities
It isn't FDA-approved for arthritis, but the effect is real for the right patient
"A Genetic Test You Don't Need"